Reform Bill Allows FDA Interim Data Reviews, Building Off Early IDE Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA would be authorized under HR 3580, "The Medical Device Amendments of 2001," to conduct premarket approval reviews of designated "priority" devices using interim data from clinical trials